arrow
X

Xue-Song Sun

Sun Yat-sen University Cancer Center
H指数:18
被引数:1,222

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Epstein–Barr virus DNA-guided chemoradiotherapy for patients with low-risk locoregionally advanced nasopharyngeal carcinoma: a secondary 5-year follow-up analysis of an open-label, randomised controlled, phase 2 non-inferiority trial

Epstein–Barr病毒DNA指导的化疗放疗用于低危局部区域晚期鼻咽癌患者的治疗:一项开放标签、随机对照、II期非劣效性试验的5年随访二次分析

2025-10-300
OAAI
[18F] Fluorodeoxyglucose positron emission tomography/computed tomography scan and liquid biopsy at 12 weeks posttreatment for surveillance of locoregionally advanced nasopharyngeal carcinoma

[18F]氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描检查及液体活检,于治疗后12周进行,用于监测局部晚期鼻咽癌。

2025-10-010
PRE
TACTC-2 trial: Efficacy of pembrolizumab ± chemotherapy first-line therapy in advanced non-small cell lung cancer patients with PD-L1 expression ≥50% adjusting in accordance with CtDNA

TACTC-2试验:评估PD-L1表达≥50%的晚期非小细胞肺癌患者中,帕博利珠单抗±化疗一线治疗的疗效,并依据CtDNA进行调节。

2024-09-011
PRE
Paclitaxel liposome, cisplatin and 5-fluorouracil-based induction chemotherapy followed by de-escalated intensity- modulated radiotherapy with concurrent cisplatin in stage IVA-IVB childhood nasopharyngeal carcinoma in endemic area: a phase II, single-arm trial
2023-11-016
OAAI
Camrelizumab combined with apatinib in patients with first-line platinum-resistant or PD-1 inhibitor resistant recurrent/metastatic nasopharyngeal carcinoma: a single-arm, phase 2 trial

Camrelizumab联合阿帕替尼治疗一线铂类耐药或PD-1抑制剂耐药复发/转移性鼻咽癌的单臂2期临床试验

2023-08-1413
OAAI
RETRACTION: Endogenous production of C-C motif chemokine ligand 2 by nasopharyngeal carcinoma cells drives radioresistance-associated metastasis (Retraction of Vol 468, Pg 27, 2020)
2023-04-010
OA
Management of suboptimal response to induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: Re-induction therapy or direct to Radiotherapy?

局部晚期鼻咽癌对诱导化疗的次优反应的管理: 再诱导治疗还是直接放疗?

2021-10-019
PREAI
Development and validation of a normal tissue complication probability model for acquired nasal cavity stenosis and atresia after radical radiotherapy for nasopharyngeal carcinoma

鼻咽癌根治性放疗后获得性鼻腔狭窄和闭锁的正常组织并发症概率模型的建立与验证

2021-07-012
OAAI
Nomogram for the prediction of primary distant metastasis of nasopharyngeal carcinoma to guide individualized application of FDG PET/CT
2021-01-0810
PREAI